Vetace Heart 2.5mg Tabs for Cats & Dogs

	VetACE is for the treatment of heart failure in dogs, and chronic renal insufficiency and hypertrophic cardiomyopathy in cats. VetACE contains benazepril hydrochloride which is an Angiotensin Converting Enzyme inhibitor which helps control vasoconstriction of arteries and veins as well as sodium and water retention by the kidney.
Dogs Treatment of left sided heart failure in dogs, most commonly resulting from mitral regurgitation (endocardiosis) and dilated cardiomyopathy (DCM). VetACE, by inhibiting the renin angiotensin aldosterone (RAA) system, minimises the undesirable effects of vasoconstriction and sodium retention mediated by this system. VetACE leads to an extension of the life span of dogs with heart failure and also improves clinical signs, notably reduction in coughing, and improvement to the quality of life. It may be used in combination therapy with diuretics (e.g. frusemide), digoxin and antiarrhythmic drugs as necessary.
Cats VetACE is indicated for the treatment of chronic renal insufficiency in cats. In such cats, it reduces protein loss in urine and lowers systemic and intraglomerular blood pressure. It increases quality of life, particularly in advanced cases. VetACE increases the survival time in cats with a urinary protein/creatinine ratio (UPC) equal to or exceeding 0.8 before treatment, and improves the appetite in cats with a UPC ratio exceeding 1.0. It has some beneficial effects on clinical signs and cardiac remodelling in cats with feline hypertrophic cardiomyopathy (HCM) and is well tolerated. Most cases of HCM in cats will require other additional medications of which the most commonly prescribed will be a calcium channel blocker, for example diltiazem.
Doseage Should be given orally, once daily, with or without food. Heart failure in dogs The minimum recommended oral dose is 0.25 mg / kg bodyweight, given according to the following regime:
Dog Weight 2.5 mg 5 mg 20 mg 2.5 - 5kg ½ tablet > 5 -10kg 1 tablet ½ tablet 11 - 20kg 1 tablet 21 - 40kg ½ tablet 41 - 80kg 1 tablet
Chronic renal insufficiency and hypertrophic cardiomyopathy in cats The minimum recommended oral daily dose is 0.5 mg / kg bodyweight, given according to the following regime:
Weight of cat 2.5 mg 5 mg 2.5 - 5kg 1 tablet ½ tablet > 5 - 10kg 2 tablets 1 tablet
Active Constituents Benazepril hydrochloride 2.5 mg/tablet, 5 mg/tablet, 20 mg/tablet.

For more information and option to buy link to: www.petmedz.co.nz